Mark Nelson

Prof

University of Tasmania

Australia

Research Interests

Explore related searches

Professors in Australia

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Mark Nelson is a Professor at the University of Tasmania, Australia. His research focuses on public health, particularly in the areas of cardiovascular disease, mental health, and metabolic disorders in older adults. Recent publications include studies on the relationship between alcohol consumption and depression, as well as the predictive performance of cardiovascular risk models. He is actively involved in initiatives aimed at preventing stroke and improving health outcomes among older populations.

Articles (20)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (33)

Lawrence Beilin

University in Western Australia

AUSTRALIA

Mark Nelson

Research Interests

Explore related searches

Contact this professor

About

Articles (20)

Association of Year-to-Year Lipid Variability With Risk of Cognitive Decline and Dementia in Community-Dwelling Older Adults

Genetic Variants, Metabolic Dysfunction-Associated Fatty Liver Disease, and Major Health Outcomes in Older Adults

Moderate Alcohol Consumption and Risk of Depression: A Longitudinal Analysis in Community-Dwelling Older Adults

From the ASPREE investigators: Response to Wittes et al.

Sex Differences in Prescription, Initiation, and Discontinuation of Secondary Prevention Medications After Stroke

Framingham Risk Score Prediction at 12 Months in the STANDFIRM Randomized Control Trial

Predictive performance of cardiovascular disease risk prediction models in older adults: a validation and updating study

Preventing Stroke Research Priorities Project: An Initiative of Synergies to Prevent Stroke (STOPstroke)

Aspirin: latest evidence and developments

Comparison of Patients Classified as High-Risk between International Cardiovascular Disease Primary Prevention Guidelines

Antihypertensive Medication Adherence and the Risk of Vascular Events and Falls After Stroke: A Real-World Effectiveness Study Using Linked Registry Data

Effect of Initial Treatment With a Single Pill Containing Quadruple Combination of Quarter Doses of Blood Pressure Medicines Versus Standard Dose Monotherapy in Patients With Hypertension on Ambulatory Blood Pressure Indices: Results From the QUARTET Study

Effect of Low-Dose Aspirin Versus Placebo on Incidence of Anemia in the Elderly

Receipt of Mental Health Treatment in People Living With Stroke: Associated Factors and Long-Term Outcomes

COVID-19 in Vietnam and Its Impact on Road Trauma: Retrospective Study Based on National Data

Does a History of Cancer Influence the Effectiveness of Statins on Outcomes After Stroke?

Does Aspirin Prevent Incident Heart Failure in Healthy Older Adults? Examining the Evidence From the ASPREE Trial

Safety of Ceasing Aspirin Used Without a Clinical Indication After Age 70 Years: A Subgroup Analysis of the ASPREE Randomized Trial

Prognostic Value of a Polygenic Risk Score for Coronary Heart Disease in Individuals Aged 70 Years and Older

Trauma Care Training in Vietnam: Narrative Scoping Review

Collaborators (33)

Lawrence Beilin

michael bailey

Markus Schlaich

Raj Shah

Trevor Chong

Laurent Billot

Richard Gerraty

John McNeil

Johannes Tobias Neumann

Sabah Rehman

G. S. Hillis

Richard Lindley

Judith Katzenellenbogen

Michael Ernst

Thanh G. Phan

Christopher M. Reid

Hoang Phan

Viet Tran

Nadine E Andrew

Renerus Stolwyk

Joanne Ryan

David Ung

Christine Louise Farmer

Jessica Fitzpatrick

Amanda Thrift

Monique F Kilkenny

Andrew M. Tonkin

Andrew J. Palmer

Sant-Rayn Pasricha

Chenglong Yu

Vijaya Sundararajan

William Kemp

Dominique A. Cadilhac

Make your next move.